Health Science and Technology

Cities Are Blazing the Trail Toward Healthcare for All

Ensuring that all Americans have access to healthcare will be one of the most important issues in the Democratic presidential primary and the 2020 election. It is unlikely that a Democrat without a viable plan can win the nomination. While some candidates are looking toward European countries for inspiration, an answer to the uninsured crisis may be found much closer to home.

Will Congress Help Rape Victims Get Justice?

After she was raped in Seattle, Leah Griffin had to wait nearly 17 hours before being examined by a nurse. McKenna Williams waited nearly 12 hours in San Diego. Jessica Garcia had to travel from her home state of Oregon to California. All three women did what seems logical in the aftermath of sexual assault — they went to the nearest emergency room.

Battle Over Opioids: Surprising Push-Back, and Not From Dealers

The first known victims of prescription opioids were not hardened addicts who stole the drugs to get high. They were injured workers, whose treatment was driven by a narrative that changed the way doctors thought about pain. Now, says the physician who discovered those first deaths, a “huge counter-narrative” may be putting some unsuspecting patients in danger.

Green-Blooded Lizards May Hold Key to New Virus Fighters

Recent findings about the lineage of a mystifying green-blooded lizard, a toxin-resistant amphibian prevalent in the rainforests of New Guinea, may aid the development of new antiviral treatments. Famous for its glossy, emerald coating, the prasinohaema lizard is a type of skink, and bears an unsettling resemblance to the offspring of a snake and a frog. A group of scientists ventured into the jungles of New Guinea to harvest DNA samples from 52 species of skinks, including six green-blooded varieties.

Group With Ties to Trump Opioid Chief Scores Big

The Trump administration has awarded $24 million in grants to a small New England nonprofit group with ties to President Donald Trump&;s opioid czar — Elinore F. McCance-Katz — a WhoWhatWhy review of government documents reveals.

Would You Be a Human Guinea Pig for Big Pharma?

During his State of the Union speech January 30, President Donald Trump called on Congress to pass the which would allow desperate patients to take experimental drugs. The president’s endorsement virtually guarantees enactment of the bill, which passed the Senate last year.

Banned Seven Words: Censorship or Good Strategy?

The uproar over the ban of a list of words that has roiled the Centers for Disease Control and Prevention (CDC), and now the rest of the country, is understandable. The list, which a Health and Human Services official advised be omitted from the CDC&;s budget documents, would make any scientist weep. Transparency advocates have raised legitimate concerns about censorship.

Will Controversial Bill Cure or Kill Patients?

In 2016, 10-year-old lost his long battle with cancer, in part because of a viral infection that resulted from a bone marrow transplant. Hardy’s family tried to get access to a new experimental antiviral drug from Chimerix, the company developing it. The company refused, not wanting to divert time and resources from its efforts to gain FDA approval for the drug.